Ocugen Q2 R&D expenses surged driven by licensing cost for Covaxin in Canada
August 06 2021 - 8:09AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Apr 2023 to Apr 2024